Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention
- 1 December 2012
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 10 (12) , 2452-2461
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- High Residual Platelet Reactivity After ClopidogrelJACC: Cardiovascular Interventions, 2010
- Early changes in local hemostasis activation following percutaneous coronary intervention in stable angina patients: a comparison between drug-eluting and bare metal stentsJournal of Thrombosis and Thrombolysis, 2008
- Variability in Individual Responsiveness to ClopidogrelJACC, 2007
- Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of ClopidogrelCirculation, 2005
- Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary InterventionCirculation, 2005
- Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial InfarctionCirculation, 2004
- Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosisPlatelets, 2004
- Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary InterventionJAMA, 2002
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyThe Lancet, 2001
- Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery diseaseAmerican Journal of Hematology, 1999